SciELO - Scientific Electronic Library Online

 
vol.20 número1Ejercicios físicos en la prevención de hipertensión arterialEstudios de laboratorio clínico para la detección de la enfermedad renal crónica en grupos poblacionales de riesgo índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


MEDISAN

versión On-line ISSN 1029-3019

Resumen

MARTINEZ FERIA, Francisco; MATOS PINEDA, Loretta Eugenia; ACOSTA BROOKS, Soraida Cándida  y  COBIAN CABALLERO, Carlos Oliver. Clinical features of patients with small-cell lung cancer. MEDISAN [online]. 2016, vol.20, n.1, pp.42-48. ISSN 1029-3019.

A descriptive, longitudinal and retrospective observational study of 46 patients with small-cell lung cancer, diagnosed histopathologically and treated by the Care Group to patients with lung tumors in "Saturnino Lora Torres" Teaching Clinical Surgical Provincial Hospital in Santiago de Cuba, was carried out from January, 2002 to December, 2014, aimed at identifying their clinical features and evaluating their global survival. The disease prevailed in the male sex, mainly in the 55 to 74 age group, and its most frequent presentation were the bronchopneumonic and lung infiltrative hilar types, detected in a clinical and radiological way, respectively. On the other hand, the histological diagnostic was obtained mainly through the bronchoscopy with biopsy and the cytological sputum, in a limited stage, and although in most of the patients the carboplatin and etoposide combination could be apply as first line treatment, the survival at a year was less than a third part of the whole series

Palabras clave : small-cell lung cancer; chemotherapy; treatment response; survival.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons